BackSerina Therapeutics Overview

Serina Therapeutics Long Term Debt

Track Serina Therapeutics's long-term debt ($160K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$159000.00
29.96% YoYΔ $-68000.00 vs prior year quarter

Peer average

Loading

Serina Therapeutics Long Term Debt History

Loading

Serina Therapeutics vs. peers: Long Term Debt Comparison

Loading

Serina Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Serina Therapeutics (SER) FAQ

As of the most recent data (March 2026), SER shows a long-term debt of $160K. That compares with $230K in the prior-year period — down 30.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SER's long-term debt is now $160K (was $230K) — a 30.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Serina Therapeutics is outperforming or lagging.

Tracking SER's long-term debt over time shows whether Serina Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $160K That compares with $230K in the prior-year period — down 30.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Serina Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $160K) with ownership activity and broader fundamentals.

Serina Therapeutics's long-term debt is $160K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.